Received: 8 July 2020
Accepted: 7 December 2020
First Online: 5 January 2021
Ethics approval and consent to participate
: No human subjects were involved in this study. This study utilized a de-identified database, which according to the US Code of Federal Regulations (<b>45 CFR 46.102(e) (1))</b> is not considered human subjects research. Data used for this study were licensed for use from Flatiron Health, Inc.
: Not applicable.
: LMH, YH, YEZ and NRB are employees of Eli Lilly and Company. AS is an employee of Loxo Oncology, a wholly owned subsidiary of Eli Lilly and Company.